多巴丝肼片及吡拉西坦治疗帕金森病的疗效比较

Clinical Efficacy of Levodopaand Benserazide Hydrochlo-ride and Piracetam in the Treatment of Parkinson Disease

目的观察多巴丝肼片及吡拉西坦治疗帕金森病(PD)的临床疗效。方法选取本院2010年8月—2013年8月的收治的80例PD患者,将其随机分为试验组和对照组,各40例。对照组患者口服吡拉西坦治疗,试验组患者给予多巴丝肼片治疗治疗,比较两组患者的临床治疗效果。结果试验组患者的总改善率(80%)高于对照组(40%),差异有统计学意义(P<0.05)。结论对帕金森患者采用多巴丝肼片治疗,可以有效改善患者的临床症状。

Objective To observe the clinical efficacy of levodopaand benserazide hydrochlo-ride and piracetam in the treatment of Parkinson disease. Methods 80 patients with Parkinson disease were admitted to our hospital from August 2010 to August 2013,were divided into the experimental group and the control group randomly,40 cases of each group. The control group was given piracetam,the experimental group was given levodopaand benserazide hydrochlo-ride,the clinical effi-cacy of two groups were compared. Results The total improvement rate（80%）of experimental group was higher than control group（40%）,the difference was statistically significant（P ﹤0. 05）. Conclusion Levodopaand benserazide hydrochlo -ride treating Parkinson disease,which can effectively improve the clinical symptoms,the actual value is obvious.